Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Alnylam Pharmaceuticals (ALNY) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 40 quarters since 2011. Compare with ALNY stock chart to see long term trends.

ALNY stock compared to

ALNY Income Statement

Revenue, Net:163562000
Revenue Per Share:1.42
Cost of Goods & Services Sold:23024000
Selling, General & Admin Expense:166291000
Research & Development Expense:168469000
Total Operating Expenses:357784000
Operating Income:-270852000
Income Taxes:-59000
Net Income:-243540000
Earnings Per Share, Basic:-2.1
Shares Outstanding, Basic Avg:114986000

ALNY Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:10386000
Change in Accounts Receiveable:21166000
Net Cash from Operations:-123144000
Net Cash from Financing Activities:217950000
Property, Plant & Equipment Purchases:21668000
Net Cash from Investing Activities:-97888000
Net Change in Cash & Equivalents:-110000

ALNY Balance Sheet

Cash and Cash Equivalents:499046000
Accounts Receivable, Net:102413000
Inventories:75202000
Total Current Assets:2614777000
Property, Plant & Equipment, Net:465029000
Total Assets:3407061000
Accounts Payable:51966000
Total Short-Term Liabilities:585270000
Total Liabilities:2390814000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR LLC
16,468,928 sh
-605,703 sh
-4%
$2,397,876
-$131,047
Vanguard Group Inc
10,532,206 sh
-368,978 sh
-3%
$1,533,489
-$81,085
Wellington Management Group Llp
10,137,526 sh
-334,201 sh
-3%
$1,476,023
-$74,945
Blackrock Inc.
8,900,170 sh
-223,281 sh
-2%
$1,295,865
-$55,409
Price T Rowe Associates Inc /Md/
6,014,851 sh
-257,575 sh
-4%
$875,762
-$53,247
Dodge & Cox
4,677,613 sh
-26,058 sh
-1%
$681,060
-$15,601
Morgan Stanley
1,520,350 sh
10,479 sh
1%
$221,363
-$2,264
Farallon Capital Management LLC
1,200,000 sh
150,000 sh
14%
$174,720
$19,204
Invesco Ltd.
1,094,651 sh
-30,044 sh
-3%
$159,380
-$7,199
American Century Companies Inc
989,312 sh
-7,874 sh
-1%
$144,044
-$3,649
Maverick Capital Ltd
967,461 sh
-146,147 sh
-13%
$140,862
-$24,074
Gilder Gagnon Howe & Co LLC
890,416 sh
6,648 sh
1%
$129,645
-$1,250
Artal Group S.A.
800,000 sh
700,000 sh
700%
$116,480
$101,669
Northern Trust Corp
752,398 sh
-22,641 sh
-3%
$109,549
-$5,242
UBS Asset Management Americas Inc
723,225 sh
-114,402 sh
-14%
$105,301,560
-$18,759,374
Legal & General Group Plc
630,792 sh
-2,284 sh
0%
$91,843
-$1,922
Goldman Sachs Group Inc
587,560 sh
580,260 sh
7949%
$85,549
$84,468
Great West Life Assurance Co /Can/
441,561 sh
380,090 sh
618%
$845
-$8,218
Charles Schwab Investment Management Inc
400,579 sh
-229,065 sh
-36%
$58,325
-$34,932
Duquesne Family Office LLC
368,419 sh
 
$53,642

Data imported from Alnylam Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.